BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 19214145)

  • 21. Limited sampling strategy for the estimation of mycophenolic acid area under the curve in adult renal transplant patients treated with concomitant tacrolimus.
    Pawinski T; Hale M; Korecka M; Fitzsimmons WE; Shaw LM
    Clin Chem; 2002 Sep; 48(9):1497-504. PubMed ID: 12194926
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of pharmacokinetics of mycophenolic acid and its glucuronide between patients with lupus nephritis and with kidney transplantation.
    Mino Y; Naito T; Matsushita T; Otsuka A; Ushiyama T; Ozono S; Hishida A; Kagawa Y; Kawakami J
    Ther Drug Monit; 2008 Dec; 30(6):656-61. PubMed ID: 18978521
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Limited sampling strategy for the estimation of mycophenolic acid area under the plasma concentration-time curve in adult patients undergoing liver transplant.
    Zicheng Y; Weixia Z; Hao C; Hongzhuan C
    Ther Drug Monit; 2007 Apr; 29(2):207-14. PubMed ID: 17417076
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of a new enzymatic assay with a high-performance liquid chromatography/ ultraviolet detection method for therapeutic drug monitoring of mycophenolic acid in adult liver transplant recipients.
    Blanchet B; Taieb F; Conti F; Abbas H; Seydi I; Harcouet L; Dauphin A; Calmus Y; Tod M
    Liver Transpl; 2008 Dec; 14(12):1745-51. PubMed ID: 19025918
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tacrolimus in diabetic kidney transplant recipients: pharmacokinetics and application of a limited sampling strategy.
    Mendonza AE; Zahir H; Gohh RY; Akhlaghi F
    Ther Drug Monit; 2007 Aug; 29(4):391-8. PubMed ID: 17667791
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Limited sampling model for advanced mycophenolic acid therapeutic drug monitoring after liver transplantation.
    Langers P; Press RR; Inderson A; Cremers SC; den Hartigh J; Baranski AG; van Hoek B
    Ther Drug Monit; 2014 Apr; 36(2):141-7. PubMed ID: 24081208
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Population pharmacokinetics of mycophenolic acid in senile Chinese kidney transplant recipients.
    Wang CX; Meng FH; Chen LZ; Ren B; Li SX; Fei JG; Qiu J; Deng SX; Li J; Chen SY
    Transplant Proc; 2007 Jun; 39(5):1392-5. PubMed ID: 17580146
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bayesian estimation of cyclosporin exposure for routine therapeutic drug monitoring in kidney transplant patients.
    Bourgoin H; Paintaud G; Büchler M; Lebranchu Y; Autret-Leca E; Mentré F; Le Guellec C
    Br J Clin Pharmacol; 2005 Jan; 59(1):18-27. PubMed ID: 15606436
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetics of free mycophenolic acid and limited sampling strategy for the estimation of area under the curve in liver transplant patients.
    Gu Z; Chen B; Song Y; Shen B; Zhu Z; Zhang W; Xie J; Deng X; Peng C; Fan Q; Chen H
    Eur J Pharm Sci; 2012 Nov; 47(4):636-41. PubMed ID: 22917640
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Population pharmacokinetics and Bayesian estimation of mycophenolic acid concentrations in stable renal transplant patients.
    Le Guellec C; Bourgoin H; Büchler M; Le Meur Y; Lebranchu Y; Marquet P; Paintaud G
    Clin Pharmacokinet; 2004; 43(4):253-66. PubMed ID: 15005639
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical utility of a new enzymatic assay for determination of mycophenolic acid in comparison with an optimized LC-MS/MS method.
    van Gelder T; Domke I; Engelmayer J; de Fijter H; Kuypers D; Budde K; Koeger R; Luthe H; Oellerich M
    Ther Drug Monit; 2009 Apr; 31(2):218-23. PubMed ID: 19214147
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lack of an effect of oral iron administration on mycophenolic acid pharmacokinetics in stable renal transplant recipients.
    Gelone DK; Park JM; Lake KD
    Pharmacotherapy; 2007 Sep; 27(9):1272-8. PubMed ID: 17723081
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A limited sampling strategy for estimating mycophenolic acid area under the curve in adult heart transplant patients treated with concomitant cyclosporine.
    Pawinski T; Kunicki PK; Sobieszczanska-Malek M; Gralak B; Szlaska I
    J Clin Pharm Ther; 2009 Feb; 34(1):89-101. PubMed ID: 19125907
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bayesian estimation of mycophenolate mofetil in lung transplantation, using a population pharmacokinetic model developed in kidney and lung transplant recipients.
    de Winter BC; Monchaud C; Prémaud A; Pison C; Kessler R; Reynaud-Gaubert M; Dromer C; Stern M; Guillemain R; Knoop C; Estenne M; Marquet P; Rousseau A
    Clin Pharmacokinet; 2012 Jan; 51(1):29-39. PubMed ID: 22054177
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Feasibility of, and critical paths for mycophenolate mofetil Bayesian dose adjustment: pharmacological re-appraisal of a concentration-controlled versus fixed-dose trial in renal transplant recipients.
    Prémaud A; Rousseau A; Le Meur Y; Venisse N; Loichot C; Turcant A; Hoizey G; Compagnon P; Hary L; Debruyne D; Saivin S; Jacqz-Aigrain E; Marquet P
    Pharmacol Res; 2010 Feb; 61(2):167-74. PubMed ID: 19800973
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetic modeling and development of Bayesian estimators in kidney transplant patients receiving the tacrolimus once-daily formulation.
    Saint-Marcoux F; Debord J; Undre N; Rousseau A; Marquet P
    Ther Drug Monit; 2010 Apr; 32(2):129-35. PubMed ID: 20110850
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Maximum a posteriori Bayesian estimation of mycophenolic Acid area under the concentration-time curve: is this clinically useful for dosage prediction yet?
    Staatz CE; Tett SE
    Clin Pharmacokinet; 2011 Dec; 50(12):759-72. PubMed ID: 22087863
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The weight of pharmacokinetic parameters for mycophenolic acid in prediction of rejection outcome: the receiver operating characteristic curve analysis.
    Pawinski T; Durlik M; Szlaska I; Urbanowicz A; Ostrowska J; Gralak B; Majchrzak J
    Transplant Proc; 2006; 38(1):86-9. PubMed ID: 16504671
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Early phase limited sampling strategy characterizing tacrolimus and mycophenolic acid pharmacokinetics adapted to the maintenance phase of renal transplant patients.
    Miura M; Satoh S; Niioka T; Kagaya H; Saito M; Hayakari M; Habuchi T; Suzuki T
    Ther Drug Monit; 2009 Aug; 31(4):467-74. PubMed ID: 19571775
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Estimation of the area under the curve for mycophenolic acid in adult renal transplant patients with concomitant tacrolimus using a limited sampling strategy.
    Teshima D; Maiguma T; Kaji H; Otsubo K; Kitagawa N; Okabe Y; Sugitani A; Tanaka M; Oishi R
    J Clin Pharm Ther; 2008 Apr; 33(2):159-63. PubMed ID: 18315781
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.